Cargando…
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
CD155 has been implicated in migration, invasion, proliferation and apoptosis of human cancer cells, and DNA damage response caused by chemotherapeutic agents or reactive oxygen species has been shown to attribute to CD155 induction. Adriamycin (Adr) is one of the most common chemotherapeutic drugs...
Autores principales: | Gao, Jian, Zheng, Qianqian, Shao, Yue, Wang, Wei, Zhao, Chenghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153518/ https://www.ncbi.nlm.nih.gov/pubmed/30039180 http://dx.doi.org/10.1007/s10495-018-1473-8 |
Ejemplares similares
-
CD155 knockdown promotes apoptosis via
AKT/Bcl‐2/Bax in colon cancer cells
por: Zheng, Qianqian, et al.
Publicado: (2017) -
CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer
por: Zheng, Qianqian, et al.
Publicado: (2020) -
CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017) -
Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome
por: Lv, Juan, et al.
Publicado: (2023) -
Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis
por: Hu, Qiong-Dan, et al.
Publicado: (2023)